scholarly journals Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression

2013 ◽  
Vol 31 ◽  
pp. 205-215 ◽  
Author(s):  
Divya Mehta ◽  
Charles L. Raison ◽  
Bobbi J. Woolwine ◽  
Ebrahim Haroon ◽  
Elisabeth B. Binder ◽  
...  
Keyword(s):  
Lipid Metabolism ◽  
Tumor Necrosis ◽  
Treatment Resistant Depression ◽  
Treatment Resistant ◽  
Tumor Necrosis Factor Antagonist ◽  
Glucose And Lipid Metabolism ◽  
Resistant Depression ◽  
Factor Antagonist ◽  
Necrosis Factor ◽  
Predict Treatment Response

scholarly journals Inhibition of tumor necrosis factor improves sleep continuity in patients with treatment resistant depression and high inflammation

2015 ◽  
Vol 47 ◽  
pp. 193-200 ◽  
Author(s):  
Jeremy F. Weinberger ◽  
Charles L. Raison ◽  
David B. Rye ◽  
Amy R. Montague ◽  
Bobbi J. Woolwine ◽  
...  
Keyword(s):  
Tumor Necrosis Factor ◽  
Tumor Necrosis ◽  
Treatment Resistant Depression ◽  
Treatment Resistant ◽  
Sleep Continuity ◽  
Resistant Depression ◽  
Necrosis Factor

scholarly journals Efficacy of Tumor Necrosis Factor Antagonist Treatment in Patients With Refractory Ulcerative Proctitis

2020 ◽  
Vol 18 (3) ◽  
pp. 620-627.e1 ◽  
Author(s):  
Guillaume Pineton de Chambrun ◽  
Aurélien Amiot ◽  
Guillaume Bouguen ◽  
Stéphanie Viennot ◽  
Romain Altwegg ◽  
...  
Keyword(s):  
Tumor Necrosis Factor ◽  
Tumor Necrosis ◽  
Tumor Necrosis Factor Antagonist ◽  
Ulcerative Proctitis ◽  
Factor Antagonist ◽  
Necrosis Factor
Sign in / Sign up

Export Citation Format

Share Document